₹ 351.37 Cr
2.47%
NIFTY Healthcare TRI
INF966L01CG3
5000.0
1000.0
1000
Sandeep Tandon, Ankit Pande, Varun Pattani, Ayusha Kumbhat, Yug Tibrewal, Sameer Kate, Sanjeev Sharma
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Quant Healthcare Fund - Growth Option - Regular Plan | 4.96 | - | - |
| NIFTY Healthcare TRI | 10.96 | 23.1 | 13.28 |
Equity
Debt
Others
The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| Zydus Wellness Limited | 9.27 |
| ANTHEM BIOSCIENCES PRIVATE LIMITED EQ NEW FV Rs. 2/- | 9.17 |
| ASTER DM HEALTHCARE LIMITED EQ | 8.9 |
| SMS Pharmaceuticals Limited | 8.86 |
| SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/- | 8.62 |
| TREPS 04-May-2026 DEPO 10 | 7.5 |
| GLENMARK LIFE SCIENCES LIMITED EQ NEW FV Rs.2/- | 7.27 |
| HFCL LIMITED EQ NEW F.V.RE.1/- | 7.14 |
| PFIZER LIMITED EQ | 6.42 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 5.15 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 58.25 |
| Fast Moving Consumer Goods | 9.27 |
| Financial Services | 8.15 |
| Telecommunication | 7.14 |
| Consumer Services | 3.72 |
| Scheme Name | 5Y (%) |
|---|---|
| Quant Healthcare Fund Reg Gr | 0.0 |